The DOI matches its Crossref record; 135 of the 135 references it cites were found in a registry or an index.
Nanostructured Lipid Carriers for Delivery of Chemotherapeutics: A Review
Open accessAbstract
The efficacy of current standard chemotherapy is suboptimal due to the poor solubility and short half-lives of chemotherapeutic agents, as well as their high toxicity and lack of specificity which may result in severe side effects, noncompliance and patient inconvenience. The application of nanotechnology has revolutionized the pharmaceutical industry and attracted increasing attention as a significant means for optimizing the delivery of chemotherapeutic agents and enhancing their efficiency and safety profiles. Nanostructured lipid carriers (NLCs) are lipid-based formulations that have been broadly studied as drug delivery systems. They have a solid matrix at room temperature and are considered superior to many other traditional lipid-based nanocarriers such as nanoemulsions, liposomes and solid lipid nanoparticles (SLNs) due to their enhanced physical stability, improved drug loading capacity, and biocompatibility. This review focuses on the latest advances in the use of NLCs as drug delivery systems and their preparation and characterization techniques with special emphasis on their applications as delivery systems for chemotherapeutic agents and different strategies for their use in tumor targeting.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Drug delivery and nanoparticles: Applications and hazards
de Jong (2008) · International Journal of Nanomedicine · doi:10.2147/ijn.s596 · Cited by 3,848
Solid lipid nanoparticles (SLN) for controlled drug delivery â a review of the state of the art
Müller, R. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00087-4 · Cited by 3,759
Solid lipid nanoparticles Production, characterization and applications
Mehnert, W. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00105-3 · Cited by 3,150
Danhier, F., Feron, O., & Préat, V. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.08.027 · Cited by 2,800
Müller, R. H., Radtke, M., & Wissing, S. A. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00118-7 · Cited by 2,113
Nanoparticle biointerfacing by platelet membrane cloaking
Hu, C.-M. J., Fang, R. H., Wang, K.-C., Luk, B. T., Thamphiwatana, S., Dehaini, D., Nguyen, P., Angsantikul, P., Wen, C. H., Kroll, A. V., et al. (2015) · Nature · doi:10.1038/nature15373 · Cited by 1,789
Nanostructured lipid matrices for improved microencapsulation of drugs
Müller, R. H., Radtke, M., & Wissing, S. A. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00180-1 · Cited by 1,226
Solid Lipid Nanoparticles and Nanostructured Lipid Carriers: Structure, Preparation and Application
Naseri, N., Valizadeh, H., & Zakeri-Milani, P. (2015) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2015.043 · Cited by 1,116
Selective Estrogen-Receptor Modulators — Mechanisms of Action and Application to Clinical Practice
Riggs, B. L., & Hartmann, L. C. (2003) · New England Journal of Medicine · doi:10.1056/nejmra022219 · Cited by 968
Solid lipid nanoparticles (SLN) for controlled drug delivery – Drug release and release mechanism
zur Mühlen, A., Schwarz, C., & Mehnert, W. (1998) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(97)00150-1 · Cited by 945
Recent Advances in Lipid Nanoparticle Formulations with Solid Matrix for Oral Drug Delivery
Das, S., & Chaudhury, A. (2011) · AAPS PharmSciTech · doi:10.1208/s12249-010-9563-0 · Cited by 838
Nanostructured lipid carriers: Promising drug delivery systems for future clinics
Beloqui, A., Solinís, M. Á., Rodríguez-Gascón, A., Almeida, A. J., & Préat, V. (2016) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2015.09.004 · Cited by 769
Nanostructured lipid carriers (NLC) in cosmetic dermal products☆
MULLER, R., PETERSEN, R., HOMMOSS, A., & PARDEIKE, J. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.04.012 · Cited by 700
Souto, E. B., Wissing, S. A., Barbosa, C. M., & Müller, R. H. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.02.032 · Cited by 692
Nanostructured lipid carriers (NLC): A potential delivery system for bioactive food molecules
Tamjidi, F., Shahedi, M., Varshosaz, J., & Nasirpour, A. (2013) · Innovative Food Science & Emerging Technologies · doi:10.1016/j.ifset.2013.03.002 · Cited by 689
Nanostructured lipid carriers for site-specific drug delivery
Khosa, A., Reddi, S., & Saha, R. N. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.04.055 · Cited by 619
The importance of nanoparticle shape in cancer drug delivery
Truong, N. P., Whittaker, M. R., Mak, C. W., & Davis, T. P. (2015) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.950564 · Cited by 594
Silybin and Silymarin - New and Emerging Applications in Medicine
Gazak, R., Walterova, D., & Kren, V. (2007) · Current Medicinal Chemistry · doi:10.2174/092986707779941159 · Cited by 573
Factors Controlling Nanoparticle Pharmacokinetics: An Integrated Analysis and Perspective
Moghimi, S. M., Hunter, A. C., & Andresen, T. L. (2012) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134623 · Cited by 545
20 Years of Lipid Nanoparticles (SLN & NLC): Present State of Development & Industrial Applications
H. Muller, R., Shegokar, R., & M. Keck, C. (2011) · Current Drug Discovery Technologies · doi:10.2174/157016311796799062 · Cited by 544
Fang, J.-Y., Fang, C.-L., Liu, C.-H., & Su, Y.-H. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.05.008 · Cited by 518
Selective cellular uptake and induction of apoptosis of cancer-targeted selenium nanoparticles
Huang, Y., He, L., Liu, W., Fan, C., Zheng, W., Wong, Y.-S., & Chen, T. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.04.067 · Cited by 446
Nanostructured lipid carriers system: Recent advances in drug delivery
Iqbal, M. A., Md, S., Sahni, J. K., Baboota, S., Dang, S., & Ali, J. (2012) · Journal of Drug Targeting · doi:10.3109/1061186x.2012.716845 · Cited by 436
Polymeric nanoparticles for cancer therapy
Parveen, S., & Sahoo, S. K. (2008) · Journal of Drug Targeting · doi:10.1080/10611860701794353 · Cited by 427
Crystallization tendency and polymorphic transitions in triglyceride nanoparticles
Bunjes, H., Westesen, K., & Koch, M. H. J. (1996) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(95)04286-5 · Cited by 425
Doktorovova, S., Souto, E. B., & Silva, A. M. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.02.005 · Cited by 419
Mitri, K., Shegokar, R., Gohla, S., Anselmi, C., & Müller, R. H. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.05.008 · Cited by 404
Nanostructured Lipid Carriers (NLCs) for Drug Delivery and Targeting
Fang, C.-L., A. Al-Suwayeh, S., & Fang, J.-Y. (2013) · Recent Patents on Nanotechnology · doi:10.2174/187221013804484827 · Cited by 367
Progress in nanoparticles characterization: Sizing and zeta potential measurement
Xu, R. (2008) · Particuology · doi:10.1016/j.partic.2007.12.002 · Cited by 344
Potential anticancer properties and mechanisms of action of curcumin.
Vallianou, N. G., Evangelopoulos, A. A., Schizas, N., & Kazazis, C. E. (2015) · PubMed · Cited by 340
Teeranachaideekul, V., Souto, E. B., Junyaprasert, V. B., & Müller, R. H. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.01.015 · Cited by 323
Zhuang, C.-Y., Li, N., Wang, M., Zhang, X.-N., Pan, W.-S., Peng, J.-J., Pan, Y.-S., & Tang, X. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.05.005 · Cited by 318
Encapsulation of retinoids in solid lipid nanoparticles (SLN)
Volkhard Jenning, S. H. G. (2001) · Journal of Microencapsulation · doi:10.1080/02652040010000361 · Cited by 315
Nanostructured lipid carrier (NLC) based gel of celecoxib
Joshi, M., & Patravale, V. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.05.060 · Cited by 302
Schubert, M. A., & Müller-Goymann, C. C. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2005.03.006 · Cited by 297
Doktorovová, S., Kovačević, A. B., Garcia, M. L., & Souto, E. B. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.08.001 · Cited by 293
Spray-drying of solid lipid nanoparticles (SLNTM)
Freitas, C., & Müller, R. H. (1998) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(97)00172-0 · Cited by 282
Lutein and zeaxanthin in eye and skin health
Roberts, R. L., Green, J., & Lewis, B. (2009) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2008.01.011 · Cited by 275
Preparation and characteristics of monostearin nanostructured lipid carriers
Hu, F.-Q., Jiang, S.-P., Du, Y.-Z., Yuan, H., Ye, Y.-Q., & Zeng, S. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.01.040 · Cited by 269
Cytotoxicity of Solid Lipid Nanoparticles as a Function of the Lipid Matrix and the Surfactant
Müller, R. H., Rühl, D., Runge, S., Schulze-Forster, K., & Mehnert, W. (1997) · Pharmaceutical Research · doi:10.1023/a:1012043315093 · Cited by 265
Quercetin-nanostructured lipid carriers: Characteristics and anti-breast cancer activities in vitro
Sun, M., Nie, S., Pan, X., Zhang, R., Fan, Z., & Wang, S. (2014) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2013.08.032 · Cited by 263
New Perspectives of Curcumin in Cancer Prevention
Park, W., Amin, A. R. M. R., Chen, Z. G., & Shin, D. M. (2013) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-12-0410 · Cited by 260
TEERANACHAIDEEKUL, V, MULLER, R., & JUNYAPRASERT, V (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.03.022 · Cited by 250
Nanostructured lipid carriers as novel carrier for parenteral delivery of docetaxel
Liu, D., Liu, Z., Wang, L., Zhang, C., & Zhang, N. (2011) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2011.02.038 · Cited by 245
Shah, N. V., Seth, A. K., Balaraman, R., Aundhia, C. J., Maheshwari, R. A., & Parmar, G. R. (2016) · Journal of Advanced Research · doi:10.1016/j.jare.2016.03.002 · Cited by 223
Pardeike, J., Weber, S., Haber, T., Wagner, J., Zarfl, H. P., Plank, H., & Zimmer, A. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.07.040 · Cited by 216
Sjöström, B., & Bergenståhl, B. (1992) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(92)90303-j · Cited by 215
Formulation and Evaluation of Nanostructured Lipid Carrier (NLC)–based Gel of Valdecoxib
Joshi, M., & Patravale, V. (2006) · Drug Development and Industrial Pharmacy · doi:10.1080/03639040600814676 · Cited by 213
Shidhaye, S., Vaidya, R., Sutar, S., Patwardhan, A., & Kadam, V. (2008) · Current Drug Delivery · doi:10.2174/156720108785915087 · Cited by 210
Jores, K., Mehnert, W., & Mäder, K. (2003) · Pharmaceutical Research · doi:10.1023/a:1025065418309 · Cited by 185
Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery
Gonzalez-Mira, E., Egea, M. A., Souto, E. B., Calpena, A. C., & García, M. L. (2011) · Nanotechnology · doi:10.1088/0957-4484/22/4/045101 · Cited by 180
Characterization of indomethacin-loaded lipid nanoparticles by differential scanning calorimetry
Castelli, F., Puglia, C., Sarpietro, M. G., Rizza, L., & Bonina, F. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.08.011 · Cited by 178
Tsai, M.-J., Wu, P.-C., Huang, Y.-B., Chang, J.-S., Lin, C.-L., Tsai, Y.-H., & Fang, J.-Y. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.12.009 · Cited by 177
Araújo, J., Nikolic, S., Egea, M. A., Souto, E. B., & Garcia, M. L. (2011) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2011.06.025 · Cited by 171
Comparison of wax and glyceride solid lipid nanoparticles (SLN®)
Jenning, V., & Gohla, S. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00426-3 · Cited by 168
Talegaonkar, S., & Bhattacharyya, A. (2019) · AAPS PharmSciTech · doi:10.1208/s12249-019-1337-8 · Cited by 165
Q10-loaded NLC versus nanoemulsions: Stability, rheology and in vitro skin permeation
Junyaprasert, V. B., Teeranachaideekul, V., Souto, E. B., Boonme, P., & Müller, R. H. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.05.020 · Cited by 163
Cirri, M., Maestrini, L., Maestrelli, F., Mennini, N., Mura, P., Ghelardini, C., & Mannelli, L. D. C. (2018) · Drug Delivery · doi:10.1080/10717544.2018.1529209 · Cited by 161
Recent Advances and Patents on Solid Lipid Nanoparticles
Sawant, K. K., & Dodiya, S. S. (2008) · Recent Patents on Drug Delivery & Formulation · doi:10.2174/187221108784534081 · Cited by 158
Cirri, M., Bragagni, M., Mennini, N., & Mura, P. (2012) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.07.015 · Cited by 155
How, C. W., Abdullah, R., Manickam, S., & Rosli, R. (2013) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2013.08.009 · Cited by 152
Psoralen and Ultraviolet A Light Therapy for Psoriasis
Stern, R. S. (2007) · New England Journal of Medicine · doi:10.1056/nejmct072317 · Cited by 149
Štecová, J., Mehnert, W., Blaschke, T., Kleuser, B., Sivaramakrishnan, R., Zouboulis, C. C., Seltmann, H., Körting, H. C., Kramer, K. D., & Schäfer‐Korting, M. (2007) · Pharmaceutical Research · doi:10.1007/s11095-006-9225-9 · Cited by 140
Souto, E. B., & Müller, R. H. (2006) · Journal of Microencapsulation · doi:10.1080/02652040500435295 · Cited by 138
Formulation and Evaluation of Lidocaine Lipid Nanosystems for Dermal Delivery
Pathak, P. O., & Nagarsenker, M. S. (2009) · AAPS PharmSciTech · doi:10.1208/s12249-009-9287-1 · Cited by 137
Curcumin and Inflammatory Bowel Disease: Potential and Limits of Innovative Treatments
Brumatti, L. V., Marcuzzi, A., Tricarico, P. M., Zanin, V., Girardelli, M., & Bianco, A. M. (2014) · Molecules · doi:10.3390/molecules191221127 · Cited by 137
Jia, L., Zhang, D., Li, Z., Duan, C., Wang, Y., Feng, F., Wang, F., Liu, Y., & Zhang, Q. (2010) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2010.06.008 · Cited by 136
El-Bahr, S. M. (2014) · Phytotherapy Research · doi:10.1002/ptr.5239 · Cited by 134
Fathi, H. A., Allam, A., Elsabahy, M., Fetih, G. N., & El‐Badry, M. (2017) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2017.11.064 · Cited by 134
Baboota, S., Shah, F. M., Javed, A., & Alka, A. (2009) · Journal of drug targeting · doi:10.1080/10611860902718672 · Cited by 128
Kasongo, W. A., Pardeike, J., Müller, R. H., & Walker, R. B. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22711 · Cited by 127
Mendes, I. T., Ruela, A. L. M., Carvalho, F. C., Freitas, J. T. J., Bonfílio, R., & Pereira, G. R. (2019) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2019.02.007 · Cited by 125
Vitorino, C., Almeida, A. J., Sousa, J., Lamarche, I., Gobin, P., Marchand, S., Couet, W. R., Olivier, J., & Pais, A. A. C. C. (2013) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.12.004 · Cited by 123
Chen, Y., Pan, L., Jiang, M., Li, D., & Jin, L. (2015) · Drug Delivery · doi:10.3109/10717544.2015.1049719 · Cited by 122
Nanoparticulate lipid dispersions for bromocriptine delivery: Characterization and in vivo study
Esposito, E., Mariani, P., Ravani, L., Contado, C., Volta, M., Bido, S., Drechsler, M., Mazzoni, S., Menegatti, E., Morari, M., et al. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.10.015 · Cited by 121
Jia, T., Zhang, L., Duan, Y., Zhang, M., Wang, G., Zhang, J., & Zhao, Z. (2014) · Cancer Cell International · doi:10.1186/s12935-014-0126-4 · Cited by 118
Zhang, J., Xiao, X. S., Zhu, J., Gao, Z., Lai, X., Zhu, X., & Mao, G. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s161163 · Cited by 118
Pardeike, J., Schwabe, K., & Müller, R. H. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.06.007 · Cited by 111
Liu, D., Liu, F., Liu, Z., Wang, L., & Zhang, N. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200402e · Cited by 108
Lipid Nanoparticles as Drug/Gene Delivery Systems to the Retina
del Pozo‐Rodríguez, A., Delgado, D., Rodríguez‐Gascón, A., & Solinís, M. Á. (2013) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2012.0128 · Cited by 107
Nikolic, S., Keck, C. M., Anselmi, C., & Müller, R. H. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.05.010 · Cited by 107
Liu, R., Liu, Z., Zhang, C., & Zhang, B. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23251 · Cited by 107
Baicalein protects the brain against neuron impairments induced by MPTP in C57BL/6 mice
Mu, X. L., He, G., Yuan, X., Li, X., & Du, G. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.01.011 · Cited by 94
Ruktanonchai, U., Bejrapha, P., Sakulkhu, U., Opanasopit, P., Bunyapraphatsara, N., Junyaprasert, V. B., & Puttipipatkhachorn, S. (2009) · AAPS PharmSciTech · doi:10.1208/s12249-009-9193-6 · Cited by 93
Potential Use of Nanostructured Lipid Carriers for Topical Delivery of Flurbiprofen
González‐Mira, E., Nikolic, S., García, M. L., Egea, M. A., Souto, E. B., & Calpena, A. C. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22271 · Cited by 91
Sabzichi, M., Samadi, N., Mohammadian, J., Hamishehkar, H., Akbarzadeh, M., & Molavi, O. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.04.042 · Cited by 91
The Delivery Strategy of Paclitaxel Nanostructured Lipid Carrier Coated with Platelet Membrane
Bang, K.-H., Na, Y., Huh, H. W., Hwang, S., Kim, M., Kim, M., Lee, H.-K., & Cho, C. (2019) · Cancers · doi:10.3390/cancers11060807 · Cited by 89
Wang, J., Liu, K., Sung, K. C., Tsai, C.-Y., & Fang, J. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.06.008 · Cited by 88
Chen, S., Liu, W., Wan, J., Cheng, X., Gu, C., Zhou, H., Chen, S., Zhao, X., Tang, Y., & Yang, X. (2012) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2011.650648 · Cited by 88
Zhong, Q., & Zhang, L. (2019) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2019.102033 · Cited by 87
Patil-Gadhe, A., Kyadarkunte, A., Patole, M., & Pokharkar, V. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.07.007 · Cited by 84
Microfluidics: a transformational tool for nanomedicine development and production
Garg, S., Heuck, G., Ip, S. Y., & Ramsay, E. (2016) · Journal of drug targeting · doi:10.1080/1061186x.2016.1198354 · Cited by 83
A novel calcium silicate based microspheres of repaglinide: In vivo investigations
Jain, S. K., Agrawal, G. P., & Jain, N. K. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.04.005 · Cited by 82
Lababidi, N., Sigal, V., Koenneke, A., Schwarzkopf, K. R. G., Manz, A., & Schneider, M. (2019) · Beilstein Journal of Nanotechnology · doi:10.3762/bjnano.10.220 · Cited by 82
Improved and Safe Transcorneal Delivery of Flurbiprofen by NLC and NLC-Based Hydrogels
González‐Mira, E., Nikolić, S., Calpena, A. C., Egea, M. A., Souto, E. B., & García, M. L. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22784 · Cited by 76
Zhang, X., Pan, W., Gan, L., Zhu, C., Gan, Y., & Nie, S. (2008) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.56.1645 · Cited by 75
Diclofenac sodium-loaded solid lipid nanoparticles prepared by emulsion/solvent evaporation method
Liu, D., Jiang, S., Shen, H., Qin, S., Liu, J., Zhang, Q., Li, R., & Xu, Q. (2010) · Journal of Nanoparticle Research · doi:10.1007/s11051-010-9998-y · Cited by 75
Delivery of retinoic acid to LNCap human prostate cancer cells using solid lipid nanoparticles
Akanda, M., Rai, R., Slipper, I. J., Chowdhry, B. Z., Lamprou, D. A., Getti, G. T. M., & Douroumis, D. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.07.042 · Cited by 73
Hwang, T., Aljuffali, I. A., Hung, C., Chen, C., & Fang, J. (2015) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2015.04.011 · Cited by 73
Bondì, M. L., Craparo, E. F., Giammona, G., Cervello, M., Azzolina, A., Diana, P., Martorana, A., & Cirrincione, G. (2007) · Drug Delivery · doi:10.1080/10717540600739914 · Cited by 73
Emami, J., Yousefian, H., & Sadeghi, H. (2018) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/jpps30117 · Cited by 72
Brugè, F., Damiani, E., Puglia, C., Offerta, A., Armeni, T., Littarru, G. P., & Tiano, L. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.06.075 · Cited by 70
Emami, J., Rezazadeh, M., Sadeghi, H., & Khadivar, K. (2016) · Pharmaceutical Development and Technology · doi:10.1080/10837450.2016.1189933 · Cited by 70
Csányi, E., Sütő, B., Berkó, S., Kozma, G., Kukovecz, Á., Budai-Szűcs, M., Erős, G., Kemény, L. V., Sztojkov‐Ivanov, A., & Gaspar, R. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s99198 · Cited by 68
Apomorphine in Dopaminergic Therapy
Subramony, J. A. (2006) · Molecular Pharmaceutics · doi:10.1021/mp060012c · Cited by 67
Jansook, P., Fülöp, Z., & Ritthidej, G. C. (2019) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2019.1569023 · Cited by 67
Gade, S., Patel, K. K., Gupta, C. R., Anjum, M. M., Deepika, D., Agrawal, A. K., & Singh, S. K. (2019) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2019.04.005 · Cited by 67
Nanostructured lipid carriers as novel drug delivery system for lung cancer gene therapy
Han, Y., Li, Y., Zhang, P., Sun, J., Li, X., Sun, X., & Kong, F. (2015) · Pharmaceutical Development and Technology · doi:10.3109/10837450.2014.996900 · Cited by 66
Nanostructured lipid carriers for MicroRNA delivery in tumor gene therapy
Wang, H., Liu, S., Li, J., Chu, F., Zhou, Y., He, Z., Guo, M., Chen, C., & Xu, L. (2018) · Cancer Cell International · doi:10.1186/s12935-018-0596-x · Cited by 64
Development of nanostructured lipid carrier for dacarbazine delivery
Almoussalam, M., Moia, C., & Zhu, H. (2015) · International nano letters. · doi:10.1007/s40089-015-0161-8 · Cited by 63
Nafee, N. A., Makled, S., & Boraie, N. A. (2018) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2018.10.003 · Cited by 63
Breithaupt, H., Dammann, A. A., & Aigner, K. (1982) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00265388 · Cited by 59
Hsu, S.-H., Wen, C.-J., Al‐Suwayeh, S. A., Chang, H., Yen, T., & Fang, J. (2010) · Nanotechnology · doi:10.1088/0957-4484/21/40/405101 · Cited by 59
Pan, S.-Y., Yang, R., Dong, H., Yu, Z., & Ko, K. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.09.011 · Cited by 57
Spray drying of fenofibrate loaded nanostructured lipid carriers
Xia, D., Shrestha, N., van de Streek, J., Mu, H., & Yang, M. (2016) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2016.01.001 · Cited by 56
Tian, B., Luo, Q., Song, S., Liu, D., Pan, H., Zhang, W., He, L., Shi-lin, M., Yang, X., & Pan, W. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22813 · Cited by 55
Liang, Y., Tian, B., Zhang, J., Li, K., Wang, L., Han, J., & Wu, Z. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s121262 · Cited by 55
Yang, J., Ju, Z., & Dong, S. (2017) · Drug Delivery · doi:10.1080/10717544.2016.1236849 · Cited by 54
Encapsulation of cannabinoid drugs in nanostructured lipid carriers
Esposito, E., Drechsler, M., Cortesi, R., & Nastruzzi, C. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.03.005 · Cited by 53
Abdolahpour, S., Toliyat, T., Omidfar, K., Modjtahedi, H., Wong, A. J., Rasaee, M. J., Kashanian, S., & Paknejad, M. (2017) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2017.1296847 · Cited by 49
Puglia, C., Santonocito, D., Ostacolo, C., Sommella, E., Campiglia, P., Carbone, C., Drago, F., Pignatello, R., & Bucolo, C. (2020) · Nanomaterials · doi:10.3390/nano10020287 · Cited by 48
Investigation of Nanostructured Lipid Carriers for Transdermal Delivery of Flurbiprofen
Han, F., Li, S., Yin, R., Shi, X., & Jia, Q. (2008) · Drug Development and Industrial Pharmacy · doi:10.1080/03639040701833708 · Cited by 46
Belachew, S. A., Erku, D., Mekuria, A. B., & Gebresillassie, B. M. (2016) · Drug Healthcare and Patient Safety · doi:10.2147/dhps.s116924 · Cited by 43
Kang, Q., Liu, J., Zhao, Y., Liu, X., Liu, X., Wang, Y., Mo, N.-L., & Wu, Q. (2018) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2018.1503599 · Cited by 43
Carvajal-Vidal, P., Fábrega, M.-J., Espina, M., Calpena, A. C., & García, M. L. (2019) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2019.102026 · Cited by 42
Characterization and Imaging of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers
Üner, M. (2015) · Springer eBooks · doi:10.1007/978-3-319-15338-4_3 · Cited by 41
Lee, S. G., Kim, C. H., Sung, S. W., Lee, E. S., Goh, M. S., Yoon, H. Y., Kang, M. J., Lee, S. K., & Choi, Y. W. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s166021 · Cited by 37
Chen, Q., Jiao, D., Wang, L., Wang, L., Hu, H., Song, J., Yan, J., Wu, L., & Shi, J. (2015) · Molecular BioSystems · doi:10.1039/c4mb00336e · Cited by 31
Anti-inflammatory activity of injectable dexamethasone acetate-loaded nanostructured lipid carriers
Xu, X., Zhao, C., Yang, H., Jian, Y., Zhang, Z., & Huang, Y. (2011) · Drug Delivery · doi:10.3109/10717544.2011.589087 · Cited by 29
Sjöström, B., & Bergenståhl, B. (1992) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(92)90051-3 · Cited by 26
Kasongo, K. W., Jansch, M., Müller, R. H., & Walker, R. B. (2010) · Journal of Liposome Research · doi:10.3109/08982104.2010.539186 · Cited by 25
Antioxidants and Skin Care: The Essentials
Graf, J. (2009) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0b013e3181c2a571 · Cited by 23
Kyadarkunte, A., Patole, M. S., & Pokharkar, V. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.12.044 · Cited by 21
Lakkadwala, S., Nguyen, S., Lawrence, J. G., Nauli, S. M., & Nesamony, J. (2014) · Journal of Microencapsulation · doi:10.3109/02652048.2014.898707 · Cited by 15
Cited by
Tenchov, R., Bird, R., Curtze, A. E., & Zhou, Q. (2021) · ACS Nano · doi:10.1021/acsnano.1c04996 · Cited by 2,221
Solid Lipid Nanoparticles vs. Nanostructured Lipid Carriers: A Comparative Review
Viegas, C., Patrício, A. B., Prata, J. M., Nadhman, A., Chintamaneni, P. K., & Fonte, P. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15061593 · Cited by 524
Nanocarriers-Mediated Drug Delivery Systems for Anticancer Agents: An Overview and Perspectives
Edis, Z., Wang, J., Waqas, M. K., Ijaz, M., & Ijaz, M. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s289443 · Cited by 390
Advancements in nanoparticle-based treatment approaches for skin cancer therapy
Zeng, L., Gowda, B. H. J., Ahmed, M. G., Abourehab, M. A. S., Chen, Z.-S., Zhang, C., Li, J., & Kesharwani, P. (2023) · Molecular Cancer · doi:10.1186/s12943-022-01708-4 · Cited by 365
Lipid Nanoparticles as Carriers for Bioactive Delivery
Dhiman, N., Awasthi, R., Sharma, B., Kharkwal, H., & Kulkarni, G. T. (2021) · Frontiers in Chemistry · doi:10.3389/fchem.2021.580118 · Cited by 345
Metadata
- Authors
- Haider, M., Abdin, S. M., Kamal, L., & Orive, G.
- Venue
- Pharmaceutics
- Publisher
- MDPI AG
- Published
- 2020-03-23
- Volume
- 12
- Issue
- 3
- Pages
- 288
- ISSN
- 1999-4923 (ISSN-L)
- OpenAlex
- W3012817514
- Cited by
- 451
- References
- 135
- FWCI
- 21.09
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.